Mannosulfan

Mannosulfan
Clinical data
Other names	[(2R,3S,4S,5R)-3,4-dihydroxy-2,5,6-tris(methylsulfonyloxy)hexyl] methanesulfonate
ATC code	L01AB03 ( WHO );
Identifiers
	IUPAC name 1,2,5,6-Tetrakis-O-(methylsulfonyl)-D-mannitol;
CAS Number	7518-35-6 ;
PubChem CID	24140 ;
ChemSpider	16736959 ;
UNII	135FQ40L36 ;
Chemical and physical data
Formula	C10H22O14S4
Molar mass	494.51 g·mol−1
3D model (JSmol)	Interactive image ;
	SMILES CS(=O)(=O)OC[C@H]([C@H]([C@@H]([C@@H](COS(=O)(=O)C)OS(=O)(=O)C)O)O)OS(=O)(=O)C;
	InChI InChI=1S/C10H22O14S4/c1-25(13,14)21-5-7(23-27(3,17)18)9(11)10(12)8(24-28(4,19)20)6-22-26(2,15)16/h7-12H,5-6H2,1-4H3/t7-,8-,9-,10-/m1/s1; Key:UUVIQYKKKBJYJT-ZYUZMQFOSA-N;
	(verify)

Last updated December 27, 2025

Mannosulfan (INN) is an alkylating agent with the potential for the treatment of cancer. It is not approved by the United States FDA for cancer treatment. Research suggests it is less toxic than the alkyl sulfonate Busulfan.^[1]

References

↑ Jeswani G, Paul SD (2017). "Recent Advances in the Delivery of Chemotherapeutic Agents". Nano- and Microscale Drug Delivery Systems. pp. 281–98. doi:10.1016/B978-0-323-52727-9.00015-7. ISBN 978-0-323-52727-9.

External links

Media related to Mannosulfan at Wikimedia Commons

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] Jeswani G, Paul SD (2017). "Recent Advances in the Delivery of Chemotherapeutic Agents". Nano- and Microscale Drug Delivery Systems. pp. 281–98. doi:10.1016/B978-0-323-52727-9.00015-7. ISBN 978-0-323-52727-9.

[1]